Quick Facts
| Property | Value |
|---|---|
| Category | Growth Factor Peptide |
| Risk Level | Experimental |
| Research Status | Limited Human Research / Primarily Mechanistic Evidence |
| Administration | Subcutaneous Injection |
| Typical Frequency | Post-Workout (Commonly Discussed) |
| Estimated Half-Life | Very Short-Acting (Reported) |
| Primary Research Interest | Recovery / Muscle Repair / Training Adaptation |
This material is provided strictly for educational and informational purposes related to peptide research and experimental growth-factor compounds. Mechano Growth Factor (MGF) is a biologically active IGF-1 splice variant associated with tissue-repair and regenerative signaling pathways. Information presented here should not be interpreted as medical advice, treatment recommendations, or encouragement of unsupervised use.
1. Summary
Mechano Growth Factor (MGF) is a splice variant of the IGF-1 gene that is naturally expressed in response to tissue injury, mechanical loading, and muscle stress. Interest in MGF emerged from observations that MGF expression increases following resistance exercise and tissue damage, leading researchers to investigate its potential role in muscle repair and adaptation.
However, one of the most important findings in the literature is that the naturally occurring MGF splice variant and the synthetic peptide sold as “MGF” are not necessarily the same thing. Multiple reviews emphasize that substantial uncertainty remains regarding how closely commercial MGF peptides replicate endogenous MGF biology.
What People Commonly Claim
- Enhanced muscle growth
- Improved recovery
- Accelerated tissue repair
- Satellite-cell activation
- Improved training adaptation
- Localized anabolic effects
- Post-workout muscle regeneration
What the Literature Actually Shows
- MGF is a naturally occurring IGF-1 splice variant induced by tissue stress and mechanical loading.
- Evidence supports a role in tissue repair and regeneration signaling.
- Research suggests involvement in satellite-cell and regenerative pathways.
- Most evidence comes from mechanistic, animal, or cellular studies.
- Human clinical data remain extremely limited.
- Several reviews explicitly caution against assuming that synthetic MGF peptides reproduce endogenous MGF biology.
CKF Transparency Note: MGF may represent one of the largest gaps between peptide-community enthusiasm and available human evidence. While endogenous MGF biology is well documented, evidence supporting the efficacy of commercially available injected MGF peptides remains limited. Several published reviews have highlighted unresolved questions regarding whether synthetic MGF products truly replicate naturally occurring MGF signaling.
2. Reconstitution Guide
- Vial Size: 2 mg
- Dilutant Type: BAC Water
- Amount of Dilutant Added: 2 mL
- Final Concentration: 1.00 mg/mL
At this concentration:
• 100 mcg = 0.100 mL (10.0 units)
• 300 mcg = 0.300 mL (30.0 units)
3. Route of Administration
Standard MGF is most commonly discussed as a post-workout subcutaneous injectable peptide within research and performance-enhancement communities.
- Primary Route: SubQ Injection
- Preferred Timing: Post-workout (theoretical rationale)
- Administration Notes: Post-workout timing is based primarily on endogenous MGF expression patterns observed following tissue stress and exercise rather than direct clinical evidence supporting injected peptide timing.
4. Typical Research Protocols
- Product Strength: 1.00 mg/mL
- Typical Delivered Amount: 100–300 mcg post-workout
- Frequency: Commonly used after training sessions
- Cycle Length: No standardized protocol exists
- Special Notes: Published literature does not establish standardized dosing protocols for synthetic MGF peptides. Most protocol discussions originate from experimental and bodybuilding communities rather than controlled human clinical trials. Evidence-based dosing recommendations therefore remain limited.
5. Mechanism of Action
MGF is generated through alternative splicing of the IGF-1 gene and appears to participate in tissue-repair and regenerative signaling following mechanical stress or injury. Research suggests involvement in satellite-cell activation, regeneration pathways, and adaptive responses to tissue damage.
- Tissue-repair signaling
- Regenerative pathway activation
- Satellite-cell involvement
- Adaptive response to mechanical loading
- Growth-factor pathway interaction
- Muscle-repair signaling
Importantly, several researchers have emphasized that the biological actions of synthetic MGF peptides may not fully mirror the actions of endogenous MGF splice variants.
6. Potential Benefits
- Potential support for recovery signaling
- Potential support for muscle-repair pathways
- Possible enhancement of regenerative signaling
- Potential training-adaptation support
- Possible satellite-cell activation effects
- Potential synergy with resistance training
7. Potential Risks / Side Effects
Experimental
- Injection-site irritation
- Unknown long-term safety profile
- Potential abnormal growth signaling concerns
- Limited human safety data
- Limited pharmacokinetic data
- Significant uncertainty regarding biological activity of commercial products
The greatest risk associated with MGF may not be a known side effect but rather the limited evidence base supporting efficacy and long-term safety. Published reviews repeatedly identify substantial unanswered questions regarding MGF biology and therapeutic application.
8. Half-Life
Standard MGF is generally described as a very short-acting peptide, although robust pharmacokinetic characterization remains limited.
Much of the post-workout administration rationale originates from the observation that endogenous MGF expression appears transient and responsive to mechanical stress. However, direct evidence establishing an optimal administration window for synthetic MGF peptides remains lacking.
Consequently, many half-life and timing claims should be viewed as theoretical rather than firmly established by human clinical research.
9. Storage Information
- Store refrigerated before and after reconstitution
- Protect from direct light exposure
- Avoid repeated freeze-thaw cycles
- Maintain sterile handling practices during preparation
10. Contraindications / Warnings
- Active cancer concerns
- Pregnancy or breastfeeding
- Known hypersensitivity to peptide compounds
- Use alongside multiple growth-factor compounds without supervision
- Individuals seeking evidence-based clinical outcomes
11. Further Study
Tier 1 — Essential Reading
- Minireview: Mechano-Growth Factor: A Putative Product of IGF-I Gene Processing?
- Mechano-Growth Factor: An Important Cog or a Loose Screw in Muscle Physiology?
- Overexpression of Mechano-Growth Factor Modulates Inflammation and Enhances Skeletal Muscle Regeneration
Tier 2 — Advanced Reading
- IGF-1 Ec / MGF Expression in Growth Plate Cartilage
- Muscle Mechano Growth Factor Is Preferentially Induced in Growth Hormone Deficiency
- The Role of Mechano Growth Factor in Chondrocytes and Cartilage Defects
Additional Reading
- Localized Delivery of Mechano-Growth Factor E-Domain Peptide Preserves Cardiac Function
- Mechano Growth Factor Promotes Neurogenesis in the Aging Mouse Brain
Current Evidence Gaps
- Human clinical trials
- Standardized dosing protocols
- Pharmacokinetic characterization
- Long-term safety data
- Comparative studies of endogenous versus synthetic MGF
- Evidence supporting post-workout administration strategies
12. Research References
- PubMed
- PubMed Central (PMC)
- Exercise physiology literature
- Growth-factor biology literature
- Muscle regeneration research
- IGF-1 splice-variant research
13. Last Reviewed
June 2026